Latest News for: faron
Edit
Faron Announces Strategic Collaboration with The Institute for Cancer Research to Launch BLAZE Trial, Targeting Immunotherapy Resistance in Cancer
Pharmiweb 22 Dec 2025
Edit
Faron Presents Updated BEXMAB Data at ASH 2025: Deep and Durable Responses in HR-MDS with Favorable Safety Profile
Pharmiweb 08 Dec 2025
TURKU, FI / ACCESS Newswire / December 8, 2025 / Faron Pharmaceuticals (HEL.FARON)(LSE.FARN) - Significant efficacy observed in TP53-mutated patients with a 70% complete remission rate in the frontline HR MDS ... About Faron Pharmaceuticals Ltd.
Edit
Faron Pharmaceuticals Ltd: Grant of Options
Pharmiweb 02 Dec 2025
TURKU, FI / ACCESS Newswire / December 2, 2025 / Faron Pharmaceuticals Ltd ... About Faron Pharmaceuticals Ltd. Faron (AIM ... FARON) is a global, clinical-stage biopharmaceutical company, focused on tackling cancers via novel immunotherapies.
Edit
Faron Pharmaceuticals Ltd: Appointment of CFO
Pharmiweb 01 Dec 2025
TURKU, FI / ACCESS Newswire / December 1, 2025 / Faron Pharmaceuticals Ltd. (AIM.FARN)(First North.FARON)(HEL.FARON)(LSE.FARN), a clinical-stage biopharmaceutical company, announces the appointment of Mr ... Juho Jalkanen, CEO of Faron.
Edit
Faron's Financial Calendar for 2026
Pharmiweb 27 Nov 2025
TURKU, FI / ACCESS Newswire / November 27, 2025 / Faron Pharmaceuticals Ltd ... A separate stock exchange notice will be issued by Faron's Board of Directors to convene the meeting ... About Faron Pharmaceuticals Ltd. Faron (AIM ... Faron Pharmaceuticals.
Edit
Inside Information: Faron Intends to Issue Second Tranche of Bonds with an Aggregated Principal Amount of Eur 10 Million Under Its Convertible Bond Arrangement
Pharmiweb 24 Nov 2025
Edit
Faron Announces Two Bexmarilimab Abstracts Accepted At Ash 2025, Including An Oral Presentation On Treatment Efficacy
Pharmiweb 04 Nov 2025
Edit
Faron Hits Key Milestone With Bexmab Phase 2 Completion, Advances To Registrational Trial With Fda Alignment
Pharmiweb 03 Nov 2025
TURKU, FI / ACCESS Newswire / November 3, 2025 / Faron Pharmaceuticals (HEL.FARON)(LSE.FARN) - Having achieved all primary endpoints and secured FDA alignment, Faron formally concludes enrolment of ...
Edit
22 stories highlighting Lexington, Kentucky's rich history and culture
Lexington Herald-Leader 01 Oct 2025
Edit
These are Lexington’s oldest businesses that still operate today
Lexington Herald-Leader 29 Sep 2025
Edit
Faron Pharmaceuticals Ltd: Exercise of Options, Director Dealing and Issue of Equity
Pharmiweb 19 Sep 2025
TURKU, FI / ACCESS Newswire / September 19, 2025 / Faron Pharmaceuticals Ltd ... About Faron Pharmaceuticals Ltd. Faron (AIM ... FARON) is a global, clinical-stage biopharmaceutical company, focused on tackling cancers via novel immunotherapies.
- 1